One of the most novel and promising strategies in medical research and the fight against cancer is the combination of DNA and messenger RNA vaccines. This new book explores the therapeutic uses, the biological processes, and the difficulties related to this novel strategy for cancer immunotherapy. Offering a unique perspective on different facets of DNA- and mRNA-based cancer vaccines, the authors present a thorough overview of the constantly changing field of cancer immunotherapy, from explaining the unique aspects of tumor angiogenesis and the role that non-coding RNAs play in treatment resistance, to investigating the most recent developments in gene therapy and splicing control. The volume also looks at this fascinating field's future potential, giving cancer patients hope for less intrusive and more effective therapies.

Sonali Sundram, MPharm, is an Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, India. She was previously affiliated as a research scientist with the Indian Council of Medical Research at King George's Medical University and with S Babu Banarasi Das Northern India Institute of Technology, both in India. Her PhD (Pharmacy) work is in neurodegeneration and nanoformulation. Her areas of interest include neurodegeneration, clinical research, and artificial intelligence. She has edited several books and has organized more than 15 national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit.

Rishabha Malviya, PhD, has 15 years of research experience. He is a Professor of Pharmacy, School of Medical and Allied Sciences, Galgotias University, India. His areas of interest include formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery, and characterization of natural polymers as pharmaceutical excipients. He has authored more than 300 research and review papers for national and international journals and has 58 patents to his name. He has also published edited books and authored 170 book chapters. He is included in the list of the World's Top 2% Scientists (2020, 2021, 2022, 2023 and 2024) by Elsevier BV and Stanford University. He is reviewer, editor, and editorial board member for more than 50 national and international journals.